Changming Xia
Overview
Explore the profile of Changming Xia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bredenoord A, Dellon E, Schlag C, Cianferoni A, Xia C, Pela T, et al.
Expert Rev Gastroenterol Hepatol
. 2025 Feb;
19(2):197-209.
PMID: 39909733
Background: Standard treatments for eosinophilic esophagitis (EoE) may present adherence, tolerance, and efficacy challenges. Dupilumab 300 mg weekly is approved for the treatment of EoE in patients ≥ 1 year...
2.
Fujieda S, Pinto J, Jang D, Han J, Mims J, De Corso E, et al.
Am J Otolaryngol
. 2025 Jan;
46(2):104596.
PMID: 39889367
Purpose: The global Assessing long-teRm Outcomes in dupiluMAb (AROMA) registry study aims to characterize the long-term, real-world use of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This...
3.
Lugogo N, Soler X, Gon Y, Cote A, Hilberg O, Xia C, et al.
Adv Ther
. 2024 Dec;
42(2):849-862.
PMID: 39652256
Introduction: Patients with uncontrolled, moderate-to-severe asthma have a higher risk for exacerbations, negatively impacting lung function and quality of life. Dupilumab, a fully human monoclonal antibody, blocks interleukins 4 and...
4.
Zhang Y, Zhao Y, Fang Z, Liu J, Xia C, Hou Z, et al.
Nanophotonics
. 2024 Dec;
13(6):891-899.
PMID: 39634366
The multicore fiber amplifier, as a key component in spatial division multiplexing (SDM) communication systems, presents higher technical difficulty compared to traditional multi-channel single core fiber amplifiers, which has sparked...
5.
Jackson D, Hamelmann E, Roberts G, Bacharier L, Xia C, Gall R, et al.
J Allergy Clin Immunol Pract
. 2024 Nov;
13(3):568-575.
PMID: 39613097
Background: Elevated blood or tissue eosinophils are considered to characterize type 2 inflammation in children with asthma and are associated with increased exacerbation rates and worse asthma control. Dupilumab, a...
6.
Soler Z, Patel Z, Mullol J, Mattos J, Nash S, Xia C, et al.
Am J Rhinol Allergy
. 2024 Sep;
39(1):6-12.
PMID: 39300794
Objective: To evaluate the association between smell loss and other aspects of disease, and evaluate dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and moderate or...
7.
Lugogo N, Heffler E, Plaza V, Hilberg O, Xia C, Nash S, et al.
J Asthma Allergy
. 2024 Jun;
17:551-556.
PMID: 38860029
No abstract available.
8.
Guilbert T, Murphy K, Hamelmann E, Ross K, Gupta A, Fiocchi A, et al.
J Asthma Allergy
. 2024 Feb;
17:81-87.
PMID: 38347908
Background: Severe, uncontrolled asthma and asthma exacerbations in children are associated with abnormal lung function and airway development, and increased risk of chronic obstructive lung disease in adulthood. The rationale...
9.
Papi A, Castro M, Busse W, Langton D, Korn S, Xia C, et al.
Ann Am Thorac Soc
. 2024 Feb;
21(4):675-679.
PMID: 38300119
No abstract available.
10.
Domingo C, Rabe K, Price D, Brusselle G, Wechsler M, Xia C, et al.
ERJ Open Res
. 2023 Nov;
9(6).
PMID: 38020559
Background: Dupilumab has been shown to improve clinical outcomes long term while reducing oral corticosteroid (OCS) dose in patients with severe OCS-dependent asthma. This analysis assesses the impact of OCS...